Biology News
In-Vitro Toxicology Market, 2023 - GlobeNewswire (press release)


GlobeNewswire (press release)
Dublin, July 26, 2018 (GLOBE NEWSWIRE) -- The "In Vitro Toxicology Market" report has been added to ResearchAndMarkets.com's offering. The in vitro toxicity testing markets include methods and technologies used for toxicity testing of pharmaceuticals, ...
thehonestanalytics.com
theaerospacenews.com

Evolution of the MBA shows it still means business - The Telegraph - Telegraph.co.uk


Telegraph.co.uk
Working as a consultant in the pharmaceuticals industry, Joseph Fitzgibbon wasn't exactly in a dead end job.

Quantum Pharmaceuticals

Moscow - Russian Federation

Quantum Pharmaceuticals, The drug discovery company. Quantum Pharmaceuticals is a technology based drug discovery company. We develop a unique computational drug discovery platform (QUANTUM), provide drug discovery services, and pursue our own in-house drug discovery projects searching for novel compounds with anti-bacterial, anti-viral and anti-cancer efficacy.

Related
Quantum Pharmaceuticals
United States

Provides drug discovery using computational technology to simulates intermolecular interactions.

AFT Pharmaceuticals - A New Force In Pharmaceuticals
New Zealand

AFT Pharmaceuticals is a privately owned company with operations in both Australia and New Zealand. The company was founded in 1997 by Dr Hartley Atkinson. AFT operates as a full service pharmaceutical company and also undertakes drug development activities including clinical trials. AFT has a growing portfolio of patented and niche pharmaceuticals which are in the process of being licensed for sale outside the Australasian market.

Quantum Enigma: Physics Encounters Consciousness
United States

Information on a book by Bruce Rosenblum and Fred Kuttner examining quantum theory, its various interpretations, and the philosophical questions that arise in conjunction with it.

Prolexys Pharmaceuticals, Inc.
United States

Mapping protein-protein interactions and identify new targets for drug discovery to treat cancer and cardiovascular disease. Explains technology platforms and aetology targeted, with FAQ, company alliances and management in Salt Lake City, Utah.

MultiTarget Pharmaceuticals
United States

Manufacturer of AquaPlasmid, a system for the isolation of pure plasmid DNA. The procedure is simpler than alkaline lysis, but the DNA prep is purer than those purified by anion exchange columns, in Salt Lake City, Utah, USA.

Alnylam Pharmaceuticals
United States

Develops novel therapeutics based RNAi. Provides overview of recent drug development programs. Includes company profile and technology information.

Calando Pharmaceuticals
United States

Company developing non-viral technologies for the therapeutic use of RNAi.

RXi Pharmaceuticals
United States

Discovery-stage biotechnology company pursuing the development of RNAi therapeutics for the treatment of neurodegenerative disease, diabetes and obesity.

United States

Develops and researches proprietary immunoregulatory compounds for treatment of autoimmune and cardiovascular disorders, inflammation and cancer. Provides information about products and technologies, as well as corporate and investment data. New Haven, CT.

Beximco Pharmaceuticals Ltd.
Bangladesh

Beximco Pharmaceuticals Ltd (BPL) is a leading manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) in Bangladesh. The company is one of the largest exporter of pharmaceuticals in the country and its state-of-the-art manufacturing facilities are certified by global regulatory bodies of Australia, European Union, Gulf nations, Brazil, among others. The company is consistently building upon its portfolio and curr